Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesUse of complementary and alternative medicine: a survey in Turkish gastroenterology patients
BMC Complementary and Alternative Medicine, 10/27/09
Kav T – CAM usage in our sample of gastrointestinal patients was lower than that described in other countries and other chronic disease groups. This could be due to their low perceived efficacy, or the relatively transient duration of symptoms experienced by the sample. Healthcare professionals need however, to be aware of CAM usage in order to educate patients appropriately about possible adverse effects or drug–interactions.
Related Articles
The culture of massage therapy: Valued elements and the role of comfort, contact, connection and caring
Complementary Therapies in Medicine, 10/26/09
Relevance Score: 69%
What's New in Alternative Therapies for Asthmatic Children
Journal of Community Health Nursing, 11/06/09
Relevance Score: 68%
Is there a role for complementary therapy in the management of leukemia
Expert Review of Anticancer Therapy, 10/05/09
Relevance Score: 68%
Postdates pregnancy and complementary therapies
Complementary Therapies in Clinical Practice, 11/10/09
Relevance Score: 67%
Perceptions of group music therapy among elderly nursing home residents in Taiwan
Complementary Therapies in Medicine, 10/28/09
Relevance Score: 67%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease
Clinical and Experimental Gastroenterology, 12/09/09
Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
Gastroenterology, 12/09/09
Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
Gastroenterology, 12/09/09
Sponsor
Article Search
Sponsor